JP Morgan Chase
ARIA

JP Morgan Chase’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

JP Morgan Chase’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-229,736
Closed -$2.86M – 5413
2016
Q4 		$2.86M Buy
229,736
+92,236
+67% +$1.11M ﹤0.01% 2852
2016
Q3 		$1.88M Sell
137,500
-403,254
-75% -$4.05M ﹤0.01% 2827
2016
Q2 		$4M Buy
540,754
+232,153
+75% +$1.74M ﹤0.01% 2428
2016
Q1 		$1.97M Sell
308,601
-4,635
-1% -$26K ﹤0.01% 2709
2015
Q4 		$1.96M Sell
313,236
-50,394
-14% -$331K ﹤0.01% 2769
2015
Q3 		$2.12M Sell
363,630
-215,527
-37% -$1.66M ﹤0.01% 2708
2015
Q2 		$4.79M Buy
579,157
+28,016
+5% +$248K ﹤0.01% 2419
2015
Q1 		$4.54M Buy
551,141
+151,635
+38% +$1.12M ﹤0.01% 2416
2014
Q4 		$2.74M Sell
399,506
-1,094,709
-73% -$6.85M ﹤0.01% 2767
2014
Q3 		$8.07M Buy
1,494,215
+1,100,056
+279% +$6.42M ﹤0.01% 2066
2014
Q2 		$2.51M Buy
394,159
+170,094
+76% +$1.17M ﹤0.01% 2409
2014
Q1 		$1.81M Sell
224,065
-64,606
-22% -$503K ﹤0.01% 2595
2013
Q4 		$1.97M Sell
288,671
-387,776
-57% -$2.09M ﹤0.01% 2768
2013
Q3 		$12.4M Buy
676,447
+13,025
+2% +$253K ﹤0.01% 1625
2013
Q2 		$11.6M Buy
+663,422
New +$11.8M ﹤0.01% 1580

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JP Morgan Chase's ARIA Position: Q1 2017 in Review

JP Morgan Chase sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 229,736 shares — an estimated $2.86M sold.

JP Morgan Chase first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $12.4M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • JP Morgan Chase reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • JP Morgan Chase sold 229,736 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.86M.
  • JP Morgan Chase first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • JP Morgan Chase's Ariad Pharmaceuticals Inc position peaked at $12.4M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on JP Morgan Chase's 13F filing for Q1 2017, filed 10 May 2017.